Tom Collins is a freelance writer in South Florida who has written about medical topics from nasty infections to ethical dilemmas, runaway tumors to tornado-chasing doctors. He travels the globe gathering conference health news and lives in West Palm Beach.
News
Unassigned school epinephrine used more than assigned injectors
ORLANDO – Twenty-two percent of the time, the epinephrine use involved the unassigned stock for children with no history of anaphylaxis or allergy...
News
Peanut is most prevalent culprit in anaphylaxis PICU admits
ORLANDO – Peanut and dairy were main causes of death of all the food-induced cases.
News
Climate change is worsening allergies, expert says
ORLANDO – The evidence of climate change’s contribution to increases in allergies and asthma should be alarming physicians and policy makers.
News
App collects allergy symptoms in real time
ORLANDO – Researchers in Australia are using smartphone technology to capture information that could improve patient care and identify symptom...
News
‘Modified rush’ immunotherapy delivers good results
ORLANDO – “The beauty of it is you’ve consolidated 3 months into a day.”
News
Caring for transgender inpatients
Hospitalists will increasingly find themselves caring for patients who openly claim a gender identity outside the traditional gender categories....
News
New tracks bring focus to HM18 program
The HM18 schedule provides more flexibility than previous conferences, and attendees have more choices.
News
Phoenix Children’s Hospital integrates care from ground up
More than 1,000 physicians in the Phoenix metro area are part of a hospital network with incentive-laden contracts for meeting care and wellness...
News
Deep remission or long-term control? Choice is key in early CLL
Sequencing therapy in chronic lymphocytic leukemia depends on patient characteristics, prior therapy, frailty, and mutations.
News
‘Year of AML’ just the beginning, expert says
SAN FRANCISCO – New therapies for acute myeloid leukemia are finally being developed after a long stagnation.
News
Tailored approaches to relapsed/recalcitrant myeloma found within NCCN guidelines
SAN FRANCISCO – The approach to relapsed/refractory multiple myeloma (MM) has to be tailored patient by patient based on the biology of the...
News
Minimal residual disease measures not yet impactful for AML patients
Measuring MRD makes sense in AML patients in clinical trials, but does not add value in clinical practice.
News
ALL therapies grow, so do the complexities of choosing the order of treatments
The main challenge for the field is deciding when and how to use the increasing variety of ALL therapies.
News
High rate of cannabis use among cancer patients
Nearly a quarter of cancer patients used cannabis in the past year.